488 related articles for article (PubMed ID: 34583746)
41. Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
Haraguchi T; Kuramitsu S; Tsujimoto M; Kashima Y; Sato K; Fujita T
Catheter Cardiovasc Interv; 2024 Jan; 103(1):97-105. PubMed ID: 37975201
[TBL] [Abstract][Full Text] [Related]
42. Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions (PHOTOPAC).
Böhme T; Noory E; Beschorner U; Lerke F; Schmidt A; Scheinert D; Ito W; Zeller T; Rastan A
Vasa; 2021 Sep; 50(5):387-393. PubMed ID: 34107772
[No Abstract] [Full Text] [Related]
43. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.
Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L
BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951
[TBL] [Abstract][Full Text] [Related]
44. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
Deloose K; Bosiers M; Peeters P; Verbist J; Maene L; Beelen R; Keirse K; Hendriks J; Lauwers P; Wauters J; Verschueren M
J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131
[TBL] [Abstract][Full Text] [Related]
45. Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial.
Liao CJ; Song SH; Li T; Zhang YZAW
Vascular; 2022 Jun; 30(3):448-454. PubMed ID: 34024196
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in patients with ulcerations and gangrene - a single center experience.
Böhme T; Noory E; Beschorner U; Jacques B; Bürgelin K; Macharzina R; Kuhn LM; Nührenberg T; Neumann FJ; Zeller T
Vasa; 2021 Feb; 50(2):132-138. PubMed ID: 33118425
[No Abstract] [Full Text] [Related]
47. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months.
Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV
J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383
[TBL] [Abstract][Full Text] [Related]
48. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.
Bausback Y; Wittig T; Schmidt A; Zeller T; Bosiers M; Peeters P; Brucks S; Lottes AE; Scheinert D; Steiner S
J Am Coll Cardiol; 2019 Feb; 73(6):667-679. PubMed ID: 30765033
[TBL] [Abstract][Full Text] [Related]
49. Treatment of femoropopliteal atherosclerotic lesions using the ranger paclitaxel-coated balloon catheter: 12-month results from an all-comers registry.
Lichtenberg M; von Bilderling P; Ranft J; Niemöller K; Grell H; Briner L; Saucy F; Rassaf T; Breuckmann F
J Cardiovasc Surg (Torino); 2018 Feb; 59(1):45-50. PubMed ID: 28980462
[TBL] [Abstract][Full Text] [Related]
50. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
[TBL] [Abstract][Full Text] [Related]
51. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P;
Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153
[TBL] [Abstract][Full Text] [Related]
52. Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.
Deloose KR; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks JMH; Brunet J; Ducasse E; Levent K; Sauguet A; Vandael F; Vercauteren S; Callaert J
JACC Cardiovasc Interv; 2023 Dec; 16(23):2900-2914. PubMed ID: 38092496
[TBL] [Abstract][Full Text] [Related]
53. Drug-coated balloon for treatment of non-atherosclerotic renal artery stenosis-a multi-center study.
Song X; Fu Y; Lai Z; Di X; Zeng R; Shao J; Ni L; Liu Z; Song X; Ye W; Liu C; Liu B; Zheng Y; Chen Y
BMC Cardiovasc Disord; 2023 Oct; 23(1):510. PubMed ID: 37845604
[TBL] [Abstract][Full Text] [Related]
54. 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon.
Sachar R; Soga Y; Ansari MM; Kozuki A; Lopez L; Brodmann M; Schroë H; Ramanath VS; Diaz-Cartelle J; Zeller T;
JACC Cardiovasc Interv; 2021 May; 14(10):1123-1133. PubMed ID: 34016410
[TBL] [Abstract][Full Text] [Related]
55. [Angioplasty with Sirolimus-coated Balloon: the New Standard in the Treatment of PAD?].
Teichgräber UK; Ingwersen M
Zentralbl Chir; 2023 Oct; 148(5):438-444. PubMed ID: 37846166
[TBL] [Abstract][Full Text] [Related]
56. Safety and Efficacy of the Passeo-18 Lux Drug-Coated Balloon Catheter in Atherosclerotic Femoropopliteal Lesions: The Multicenter BIOLUX P-IV China Study.
Yang J; Yue J; Chen X; Wang H; Jiang W; Huang X; Lu X; Dong H; Li X; Fu W
Ann Vasc Surg; 2023 Jul; 93():275-282. PubMed ID: 36796585
[TBL] [Abstract][Full Text] [Related]
57. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
Herten M; Torsello GB; Schönefeld E; Stahlhoff S
Vasc Health Risk Manag; 2016; 12():341-56. PubMed ID: 27621646
[TBL] [Abstract][Full Text] [Related]
58. Long-term outcomes after paclitaxel-coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study.
Ko YG; Choi D; Rha SW; Won JH; Do YS; Lee SW; Menk JS; Kum S
Catheter Cardiovasc Interv; 2022 Dec; 100(7):1273-1283. PubMed ID: 36385562
[TBL] [Abstract][Full Text] [Related]
59. Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative.
Bertges DJ; Sedrakyan A; Sun T; Eslami MH; Schermerhorn M; Goodney PP; Beck AW; Cronenwett JL; Eldrup-Jorgensen J
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008528. PubMed ID: 32069110
[TBL] [Abstract][Full Text] [Related]
60. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
